Profile: BioOnco is a biopharmaceutical company focused exclusively on the protein based therapeutics and diagnostics. We are focused on discovering and developing advanced therapies in oncology, infectious and other diseases. We provide a full range of early stage drug development services including business planning, discovery, formulations, analytical method development and validation, toxicological supplies, preclinical studies, ICH stability studies & quality and regulatory support. We have developed proprietary technology known as Designer Vaccines Platform (DVP) . DVP can be used to develop vaccines based on DNA and recombinant protein expression in either prokaryotic or eukaryotic cells. This new platform is flexible to accommodate multiple strategies to overcome the inherent limitations of the candidate vaccine antigens.